Odalasvir

From WikiMD.org
Jump to navigation Jump to search

Odalasvir

Odalasvir (pronounced: oh-dah-las-veer) is an experimental antiviral drug used in the research for treatment of Hepatitis C. It is a second-generation NS5A inhibitor that has shown high potency in vitro against all major Hepatitis C genotypes.

Etymology

The name "Odalasvir" is derived from the chemical structure of the drug. The "Oda" part of the name refers to the oxime moiety in the chemical structure, while "lasvir" is a common suffix for antiviral drugs, particularly those targeting the NS5A protein.

Mechanism of Action

Odalasvir works by inhibiting the NS5A protein, which is essential for the replication of the Hepatitis C virus. By blocking this protein, Odalasvir prevents the virus from multiplying and spreading to new cells.

Clinical Trials

Odalasvir has been studied in several clinical trials, often in combination with other antiviral drugs. In a Phase II trial, a combination of Odalasvir and Sofosbuvir demonstrated high rates of sustained virologic response in patients with Hepatitis C.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski